Answers are grounded in this paper and cite their sources.
Observes that elevated serum alkaline phosphatase correlates with arterial stiffness and 10-year cardiovascular risk, suggesting its value as an accessible screening biomarker.
Background Serum alkaline phosphatase (ALP) has been recognized as a biomarker of cardiovascular disease (CVD) risk or mortality, recently. This study aimed to explore the association of ALP with arterial stiffness and 10-year CVD risk. Methods A total of 12539 participants without CVD who underwent health examinations including serum ALP level were retrospectively analyzed. Arterial stiffness was measured by brachial ankle pulse wave velocity (baPWV) and10-year CVD risk was evaluated by Framingham risk score (FRS). Results All participants were stratified into four groups according to the quartile of serum ALP. Participants with high ALP quartiles had higher cardiovascular parameters and baPWV, as well as an increase 10-year CVD risk. Logistic regression analysis showed that serum ALP was an independently risk factor for elevated baPWV and 10-year CVD risk after adjustment for traditional CVD risk factors in both women and men. In receiver operating characteristic (ROC) curve analysis, the area under the ROC curve (AUROC) of serum ALP for predicting elevated baPWV was 0.740 (95% CI 0.726–0.754, P < 0.001) in women, larger than that in men. Conclusions Serum ALP is independently associated with arterial stiffness and 10-year CVD risk in the general Chinese population. Our results also imply the better performance of serum ALP in women than men for predicting subclinical atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: